title: Assessing the usefulness of health-related quality-of-life trials: a clinician's perspective using two COPD examples.
abstract: OBJECTIVE
  To empower clinicians to discern when health-related quality-of-life (HRQoL) evidence from a single trial, or from constituent trials within a systematic review or meta-analysis, is compelling enough to alter clinical practice.
  
  
  METHODS
  To determine the criteria that would be most useful in assessing the quality of HRQoL data, recommendation statements or consensus guidelines that offer guidance to those conducting HRQoL trials were located through a MEDLINE search (1950-April 2009) using the search terms health-related quality of life and recommendations or guidelines.
  
  
  METHODS
  Recommendation statements or consensus guidelines that offer guidance to investigators conducting HRQoL trials were evaluated to determine what criteria would be the most useful in assessing the quality of HRQoL data.
  
  
  RESULTS
  We discuss how quality of HRQoL data may be assessed by evaluating the following broad questions: (1) Is the HRQoL analysis hypothesis-driven? (2) How is HRQoL being measured? (3) Are the HRQoL data being collected adequately and analyzed correctly? and (4) To what extent do investigators discuss the results of HRQoL analyses? Using select examples from the literature on chronic obstructive pulmonary disease, we applied the 4 broad questions in the assessment of their quality. Also, the use of scoring systems for quality rating for HRQoL data is discussed and applied to the example cases.
  
  
  CONCLUSIONS
  HRQoL data are an important outcome because they capture treatment impact on physical, social, and psychological well-being. Assessing the quality and usefulness of HRQoL data requires an understanding of the advantages, limitations, and caveats of their use. Because of the potential lack of quality in HRQoL outcomes, clinicians should thoroughly assess the validity and usefulness of the evaluation. Tools are available to aid clinicians and decision-makers in the assessment of HRQoL outcomes, but additional research needs to be conducted on the topic of quality assessment of HRQoL studies to improve the usefulness of these evaluations to clinicians.
authors.affiliation: University of Connecticut/Hartford Hospital Evidence-Based Practice Center, Hartford, CT 06102, USA.
authors.forename: Olivia J
authors.initials: OJ
authors.lastname: Phung
authors.forename: C Michael
authors.initials: CM
authors.lastname: White
authors.forename: William L
authors.initials: WL
authors.lastname: Baker
authors.forename: Craig I
authors.initials: CI
authors.lastname: Coleman
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D003657:Decision Making; D017408:Guidelines as Topic; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000523:psychology*; D011788:Quality of Life; D012107:Research Design